DFX Intelligence
Clarus Lifesciences III, L.P.
As of · the latest observation of this vehicle; each figure below carries its own filing date
HarvestFundraising status unknownADV: Venture Capital Fund
As of · the latest observation of this vehicle; each figure below carries its own filing date
4 additional principals, 1 additional placement agent, 1 event
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
What matters now
- -43%reported GAV
Reported gross assets fell from $43.3M to $24.8M between the Form ADV filings of 28 Mar 2024 and 30 Mar 2026.
The fund's assets as the adviser swears them, never its size or dry powder.
Drawing the relationship network…
Amounts, each with its basis
- Vintage
- 2014basis: form d first sale
- Target
- unknownnot announced
- First close
- unknownnever inferred from a Form D
- Final close
- unknownonly from an announcement or an LP disclosure
- Announced size
- unknown
- Form D offering
- $375Mwhat may be sold, not what was raised; file 021-211426, sworn by the adviser or filed under this vehicle
- Form D sold
- $234Mas of the filing of Jun 19, 2014, 16 investors
- First sale
- Feb 7, 2014
- Reported GAV
- $24.8Mon the Form ADV filed Mar 30, 2026; the fund's assets, never its size or dry powder
- Owners (ADV)
- 34
- Reported on ADV
- Mar 23, 2015 to Mar 30, 2026
Fundraising evidence
What counts as raisingA Form D offering is permission to sell, not a fund in market; an amount sold is never a close; an evergreen offering amended every year is not a raise.Unknown
latest Form D 2014-06-19, older than 15 months (fr-1)
evidence dated Jun 19, 2014.
Lifecycle
Harvest
Lifecycle
vintage over 7 years, still reported
age years: 12first sale: Feb 7, 2014vintage year: 2014adv gav as of: Mar 30, 2026vintage basis: Form d first saleform d sold: $234Mform d offering: $375Mform d latest filed at: Jun 19, 2014
The fund's own reporting through time
21 Form ADV filings
| Filed | Type | Gross asset value | Owners | Min. investment | Adviser-owned | Audit | |
|---|---|---|---|---|---|---|---|
| Mar 23, 2015 | Venture Capital Fund | $320M | 31 | $5.0M | 15% | yes | |
| Mar 21, 2016 | Venture Capital Fund | $368M | 31 | $5.0M | 15% | yes | |
| Mar 24, 2017 | Venture Capital Fund | $350M | 34 | $5.0M | 15% | yes | |
| Mar 28, 2018 | Venture Capital Fund | $359M | 34 | $5.0M | 15% | yes | |
| Nov 20, 2018 | Venture Capital Fund | $479M | 34 | $5.0M | 15% | yes | |
| Mar 29, 2019 | Venture Capital Fund | $367M | 34 | $5.0M | 15% | yes | |
| Jul 15, 2019 | Venture Capital Fund | $367M | 34 | $5.0M | 15% | yes | |
| Sep 4, 2019 | Venture Capital Fund | $367M | 34 | $5.0M | 15% | yes | |
| Mar 30, 2020 | Venture Capital Fund | $435M | 34 | $5.0M | 15% | yes | |
| Jun 4, 2020 | Venture Capital Fund | $436M | 34 | $5.0M | 15% | yes | |
| Mar 31, 2021 | Venture Capital Fund | $669M | 34 | $5.0M | 15% | yes | |
| Feb 9, 2022 | Venture Capital Fund | $669M | 34 | $5.0M | 15% | yes | |
| Mar 31, 2022 | Venture Capital Fund | $343M | 34 | $5.0M | 21% | yes | |
| Apr 12, 2022 | Venture Capital Fund | $343M | 34 | $5.0M | 21% | yes | |
| Jun 22, 2022 | Venture Capital Fund | $343M | 34 | $5.0M | 21% | yes | |
| Sep 6, 2022 | Venture Capital Fund | $343M | 34 | $5.0M | 21% | yes | |
| Dec 2, 2022 | Venture Capital Fund | $343M | 34 | $5.0M | 21% | yes | |
| Jan 17, 2023 | Venture Capital Fund | $343M | 34 | $5.0M | 21% | yes | |
| Mar 31, 2023 | Venture Capital Fund | $149M | 34 | $5.0M | 21% | yes | |
| Mar 28, 2024 | Venture Capital Fund | $43.3M | 34 | $5.0M | 21% | yes | |
| Mar 30, 2026 | Venture Capital Fund | $24.8M | 34 | $5.0M | 21% |
Principals and agents
7 principals on Form D, 2 placement agents
- Nicholas J. Simon Executive Officer
- Robert W. Liptak Executive Officer
- Clarus Ventures III GP, L.P. Director
- Magog & Cie Limited placement agent
- Snowbridge LLC placement agent
Service providers
4 named on Form ADV Schedule D and Form D
- AuditorDeloitte · NEW YORK, New York, United StatesForm ADV filed Mar 30, 2026 reports.adviserinfo.sec.gov
- CustodianJPMorgan · NEW YORK, New York, United StatesForm ADV filed Mar 30, 2026 reports.adviserinfo.sec.gov
- Placement agentMagog & Cie Limitedfiling date not on record sec.gov
Limited partners and their reported performance
Whose numbers these areEach row is the LP’s own number: its cash flows and its valuation policy as of its reporting date, not the fund’s. Net IRR is printed only when the LP prints one. The vintage is the LP’s definition (CalPERS: year of its first cash flow; WSIB: year of its initial investment).0 public LP reports
No public LP has reported this vehicle. The LP tape is read from public pension disclosures (see Limited partners); a fund appears here only when an LP’s report names it.
Known LPs and allocators
What these amounts and dates areA commitment date prints only when the source printed one; otherwise the row carries the date of the report that listed it. A foundation’s 990-PF line is a holding at fair value on its return, never a commitment.1 relationship, public pensions and the allocator graph, each counted once
| Allocator | Type | Amount | Date | Source |
|---|---|---|---|---|
| Richard King Mellon Foundation Dtd 01-01-47 | FOUNDATION | $97,483 fair value on the foundation's return | reported as of Dec 31, 2024 | Fact IRS Form 990 / 990-PF e-file returns |
Investments attributed to this vehicle
0
No investment attributed to this vehicle. The firm’s investments sit on the firm; a fund gets one only when a source names the vehicle.
Timeline
6 events
- Mar 31, 2023Auditor changed: Deloitte replaced EY, first reported on the Form ADV filed March 31, 2023 (previous filing January 17, 2023)Auditor changed Fact Form ADV
- Mar 30, 2020Custodian changed: First Republic Bank replaced UBS FINANCIAL SERVICES INC., first reported on the Form ADV filed March 30, 2020 (previous filing September 4, 2019)Custodian changed Fact Form ADV
- Mar 24, 2017Custodian changed: UBS FINANCIAL SERVICES INC. replaced CREDIT SUISSE SECURITIES (USA) LLC, first reported on the Form ADV filed March 24, 2017 (previous filing March 21, 2016)Custodian changed Fact Form ADV
- Mar 23, 2015Clarus Lifesciences III, L.P. first reported on Form ADV by Clarus Ventures LLC (Venture Capital Fund), GAV $320,112,974Fund first reported on Form ADV Fact Form ADV
- Jun 19, 2014Clarus Lifesciences III, L.P. filed Form D/A: $234,160,000 sold of $375,000,000, Venture Capital FundForm D filed Fact Form D
Evidence
31 observations
Every observation on this vehicle
- Entity type: Limited Partnership Jun 19, 2014 Fact Form D
- Entity type: Limited Partnership Feb 6, 2014 Fact Form D
- Form D fund type: Venture Capital Fund Jun 19, 2014 Fact Form D
- Form D fund type: Venture Capital Fund Feb 6, 2014 Fact Form D
- Form D industry group: Pooled Investment Fund Jun 19, 2014 Fact Form D
- Form D industry group: Pooled Investment Fund Feb 6, 2014 Fact Form D
- Amendment: true Jun 19, 2014 Fact Form D
- Amendment: false Feb 6, 2014 Fact Form D
- Revenue range (Form D): Not Applicable Jun 19, 2014 Fact Form D
- Revenue range (Form D): Not Applicable Feb 6, 2014 Fact Form D
- Incorporated: withinFiveYears Jun 19, 2014 Fact Form D
- Incorporated: withinFiveYears Feb 6, 2014 Fact Form D
- Jurisdiction: Delaware Jun 19, 2014 Fact Form D
- Jurisdiction: Delaware Feb 6, 2014 Fact Form D
- Amount sold (Form D): $234M Jun 19, 2014 Fact Form D
- Amount sold (Form D): $0 Feb 6, 2014 Fact Form D
- Offering amount (Form D): $375M Jun 19, 2014 Fact Form D
- Offering amount (Form D): $375M Feb 6, 2014 Fact Form D
- Exemptions: 06b, 3C, 3C.1, 3C.7 Jun 19, 2014 Fact Form D
- Exemptions: 06b, 3C, 3C.1, 3C.7 Feb 6, 2014 Fact Form D
- First sale: 2014-02-07 Jun 19, 2014 Fact Form D
- Investors (Form D): 16 Jun 19, 2014 Fact Form D
- Investors (Form D): 0 Feb 6, 2014 Fact Form D
- Minimum investment (Form D): 0 Jun 19, 2014 Fact Form D
- Minimum investment (Form D): 0 Feb 6, 2014 Fact Form D
- Securities offered: pooled Jun 19, 2014 Fact Form D
- Securities offered: pooled Feb 6, 2014 Fact Form D
- Office address: Jun 19, 2014 Fact Form D
- Office address: Feb 6, 2014 Fact Form D
- Year of incorporation: 2014 Jun 19, 2014 Fact Form D
- Year of incorporation: 2014 Feb 6, 2014 Fact Form D
Relationships across DFX
on 3 other DFX graphs
Across the graphs
Clarus Lifesciences III, L.P. is the same institution as 3 records in Allocators, RIA and Wealth and Family Offices.
Allocators1RIA and Wealth1Family Offices1
DFX found 3 relationships across 3 datasets
Which record it is in each graph, what it is called there, and how the two were matched.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
Checking your plan…
Record history
3 dated events on the change ledger, latest event first
- Fund first reported on ADV2015-03-23source on record
- Form D filed2014-06-19source on record
- Form D filed2014-02-06source on record
The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.